{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:49:17Z","timestamp":1781174957809,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.thromres.2004.11.001","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T13:49:19Z","timestamp":1105624159000},"page":"109-114","source":"Crossref","is-referenced-by-count":70,"title":["Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia\u2014a single center experience in 34 patients"],"prefix":"10.1016","volume":"116","author":[{"given":"Najib","family":"Dally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuhad","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Sarig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2004.11.001_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposal for the classification of acute leukemias","volume":"33","author":"Bennett","year":"1976","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2004.11.001_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0002-9343(84)90994-X","article-title":"Evidence for a (15;17) translocation in every patient with acute promyelocytic leukemia","volume":"76","author":"Larson","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2004.11.001_bib3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0142(19870215)59:4<748::AID-CNCR2820590414>3.0.CO;2-E","article-title":"Tissue factor activity in leukemic cells","volume":"59","author":"Andoh","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.thromres.2004.11.001_bib4","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/1097-0142(19861015)58:8<1736::AID-CNCR2820580825>3.0.CO;2-8","article-title":"Fibrinolysis in patients with acute promyelocytic leukemic and disseminated intra-vascular coagulation during heparin therapy","volume":"58","author":"Imaoka","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.thromres.2004.11.001_bib5","first-page":"126","article-title":"Evidence of fibrinogen breakdown by leukocyte enzyme in a patient with acute promyelocytic leukemia","volume":"15","author":"Sterrenberg","year":"1985","journal-title":"Haemostasis"},{"key":"10.1016\/j.thromres.2004.11.001_bib6","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood.V73.3.800.800","article-title":"Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells. Reversal of the bleeding disorder by cell differentiation","volume":"73","author":"Wijemmans","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood.V79.3.543.543","article-title":"Reassessing the hemostatic disorders associated with acute promyelocytic leukemia","volume":"79","author":"Tallman","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib8","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood.V75.11.2112.2112","article-title":"Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients","volume":"75","author":"Rodeghiero","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","author":"Huang","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib10","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood.V76.9.1704.1704","article-title":"All-trans retinoic acid as differentiation therapy for acute promyelocytic leukemia. Clinical results","volume":"7","author":"Castaigne","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib11","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood.V80.9.2176.2176","article-title":"All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and many prolong remissions in newly diagnosed acute promyelocytic leukemia, a pilot study on 26 cases","volume":"80","author":"Fenaux","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib12","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1182\/blood.V88.4.1390.bloodjournal8841390","article-title":"AIDA (all-trans retinoic acid+idarubicine) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study","volume":"88","author":"Avvisati","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib13","first-page":"1014","article-title":"Molecular remission in PML\/RAR\u03b1-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy","volume":"90","author":"Mandelli","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib14","first-page":"2","article-title":"Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid","volume":"7","author":"Dompret","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2004.11.001_bib15","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.V86.3.1072.1072","article-title":"Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia given all-trans retinoic acid","volume":"86","author":"Falanga","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib16","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V82.11.3241.3241","article-title":"Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trail","volume":"82","author":"Fenaux","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199710093371501","article-title":"All-trans retinoic acid in acute promyelocytic leukemia","volume":"337","author":"Tallman","year":"1997","journal-title":"NEJM"},{"key":"10.1016\/j.thromres.2004.11.001_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1365-2141.2000.01936.x","article-title":"Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukemia","volume":"108","author":"Di Bona","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2004.11.001_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajh.2830430305","article-title":"Four years experience with the treatment of all-trans retinoic acid in acute promyelocytic leukemia","volume":"43","author":"Xingzhong","year":"1993","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2004.11.001_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.46.1.198","article-title":"Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies","volume":"46","author":"Karahalios","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.thromres.2004.11.001_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1054\/jocn.2001.0986","article-title":"Cranial venous outflow obstruction in the pseudotumor cerebri syndrome: incidence, nature and relevance","volume":"9","author":"Johnston","year":"2002","journal-title":"J Clin. Neurosci."},{"key":"10.1016\/j.thromres.2004.11.001_bib22","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood-2003-09-3017","article-title":"Thrombophilia as a common predisposing factor in pseudotumor cerebri","volume":"103","author":"Dunkley","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000046588","article-title":"Coagulopathy of acute promyelocytic leukemia","volume":"106","author":"Falanga","year":"2001","journal-title":"Acta Haematol."},{"key":"10.1016\/j.thromres.2004.11.001_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood.V89.1.243","article-title":"Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia","volume":"89","author":"Banker","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib25","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1182\/blood.V89.12.4378","article-title":"Thrombin generation by apoptotic vascular smooth muscle cells","volume":"89","author":"Flynn","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hon.687","article-title":"Abnormalities in hemostasis in acute promyelocytic leukemia","volume":"20","author":"Kwann","year":"2002","journal-title":"Haematol. Oncol."},{"key":"10.1016\/j.thromres.2004.11.001_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V60.2.309.309","article-title":"Causes of initial remission induction failure in acute myelogenous leukemia","volume":"60","author":"Estey","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.11.001_bib28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0950-3536(87)80022-7","article-title":"Hyperleukocytic leukemia: rheological and clinical features and management","volume":"1","author":"Lichtman","year":"1987","journal-title":"Bailliere's Clin. Haematol."},{"key":"10.1016\/j.thromres.2004.11.001_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ajh.2830270109","article-title":"Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in induction","volume":"27","author":"Ventura","year":"1988","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2004.11.001_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jca.2920080404","article-title":"Management of hematological disorders and cancer","volume":"8","author":"McLeod","year":"1993","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.thromres.2004.11.001_bib31","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/1097-0142(19830901)52:5<773::AID-CNCR2820520503>3.0.CO;2-X","article-title":"Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count","volume":"52","author":"Hug","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.thromres.2004.11.001_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mpo.2950110203","article-title":"Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia","volume":"11","author":"Cuttner","year":"1983","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.thromres.2004.11.001_bib33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s002770000162","article-title":"Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis","volume":"79","author":"Thiebaut","year":"2000","journal-title":"Ann. Hematol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938480400581X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938480400581X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T09:18:38Z","timestamp":1586078318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938480400581X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S004938480400581X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2004.11.001","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}